Clinical Trial Update: Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain Management [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Adductor Canal Block with HR18034 in postsurgical pain management after total knee arthroplasty.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain Management
• Total Knee Arthroplasty

Drugs mentioned

• HR18034

Snippet

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. | Conditions: Total Knee Arthroplasty | Phase 2 | Status: UNKNOWN